DK0706401T3 - Lægemiddelafgivelsessystem - Google Patents

Lægemiddelafgivelsessystem

Info

Publication number
DK0706401T3
DK0706401T3 DK94918945T DK94918945T DK0706401T3 DK 0706401 T3 DK0706401 T3 DK 0706401T3 DK 94918945 T DK94918945 T DK 94918945T DK 94918945 T DK94918945 T DK 94918945T DK 0706401 T3 DK0706401 T3 DK 0706401T3
Authority
DK
Denmark
Prior art keywords
matrix
drug
delivery system
drug delivery
receptor
Prior art date
Application number
DK94918945T
Other languages
English (en)
Inventor
Margaret Joan Taylor
Original Assignee
Univ Montfort
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montfort filed Critical Univ Montfort
Application granted granted Critical
Publication of DK0706401T3 publication Critical patent/DK0706401T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94918945T 1993-06-30 1994-06-27 Lægemiddelafgivelsessystem DK0706401T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313484A GB9313484D0 (en) 1993-06-30 1993-06-30 Drug system ii
PCT/GB1994/001384 WO1995001186A1 (en) 1993-06-30 1994-06-27 Drug system

Publications (1)

Publication Number Publication Date
DK0706401T3 true DK0706401T3 (da) 2003-03-03

Family

ID=10738039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918945T DK0706401T3 (da) 1993-06-30 1994-06-27 Lægemiddelafgivelsessystem

Country Status (11)

Country Link
US (2) US5902607A (da)
EP (1) EP0706401B1 (da)
JP (1) JP4572008B2 (da)
AT (1) ATE228374T1 (da)
AU (1) AU7004194A (da)
DE (1) DE69431800T2 (da)
DK (1) DK0706401T3 (da)
ES (1) ES2185654T3 (da)
GB (1) GB9313484D0 (da)
PT (1) PT706401E (da)
WO (1) WO1995001186A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system
GB0116860D0 (en) * 2001-07-10 2001-09-05 Univ Montfort Gel compositions
AU2003301064A1 (en) 2002-12-17 2004-07-14 Massachusetts Institute Of Technology Stimuli-responsive systems for controlled drug delivery
GB0412631D0 (en) * 2004-06-07 2004-07-07 Cambridge Applied Polymers Ltd Polymer release system
CA2607004C (en) 2005-05-05 2016-01-26 Sensient Flavors Inc. Production of beta-glucans and mannans
US20070099820A1 (en) * 2005-10-19 2007-05-03 Smartcells, Inc. Polymer-drug conjugates
CA2671900A1 (en) * 2006-12-22 2008-07-03 The Regents Of The University Of California Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
US8906850B2 (en) 2009-01-28 2014-12-09 Smartcells, Inc. Crystalline insulin-conjugates
US8603529B2 (en) * 2009-01-28 2013-12-10 Smartcells, Inc. Polynucleotide aptamer-based cross-linked materials and uses thereof
JP2012516340A (ja) 2009-01-28 2012-07-19 スマートセルズ・インコーポレイテツド 合成コンジュゲートおよびその使用
NZ594248A (en) 2009-01-28 2015-03-27 Smartcells Inc Conjugate based systems for controlled drug delivery
CA2750223A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
JP2012520879A (ja) * 2009-03-20 2012-09-10 スマートセルズ・インコーポレイテツド 末端官能基化コンジュゲートおよびその用途
EP2408470A4 (en) 2009-03-20 2012-08-29 Smartcells Inc SOLUBLE NONDEPOT INSULIN CONJUGATE AND ITS USE
US9095623B2 (en) * 2009-03-20 2015-08-04 Smartcells, Inc. Terminally-functionalized conjugates and uses thereof
US9074015B2 (en) 2010-07-28 2015-07-07 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
US8933207B2 (en) 2010-07-28 2015-01-13 Smartcells, Inc. Drug-ligand conjugates, synthesis thereof, and intermediates thereto
US9068013B2 (en) 2010-07-28 2015-06-30 Smart Cells, Inc. Recombinant lectins, binding-site modified lectins and uses thereof
CA2902256A1 (en) * 2012-02-17 2013-08-22 Massachusetts Institute Of Technology Self-regulated peptide hydrogel for insulin delivery
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) 2013-08-15 2013-10-02 Univ Montfort Matrix gel
MX366852B (es) 2013-10-04 2019-07-25 Merck Sharp & Dohme Conjugados de insulina sensibles a glucosa.
WO2018175272A1 (en) 2017-03-23 2018-09-27 Merck Sharp & Dohme Corp. Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes
EP3727424A4 (en) 2017-12-18 2021-10-27 Merck Sharp & Dohme Corp. CONJUGATE-BASED SYSTEMS FOR CONTROLLED INSULIN RELEASE
WO2019125879A2 (en) 2017-12-18 2019-06-27 Merck Sharp & Dohme Corp. Conjugate based systems for controlled insulin delivery
CN108721605B (zh) * 2018-06-01 2022-10-14 华南师范大学 一种装载有胰岛素的纳米粒子及其应用
WO2021113986A1 (en) * 2019-12-13 2021-06-17 Folium Labs Inc. Complexes comprising a carbohydrate polymer and an active ingredient and processes for their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348387A (en) * 1979-07-31 1982-09-07 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
CA2084194C (en) * 1991-04-02 2003-05-20 Gregory John Russell-Jones Oral delivery systems for microparticles
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system

Also Published As

Publication number Publication date
JPH09501416A (ja) 1997-02-10
ATE228374T1 (de) 2002-12-15
US5902607A (en) 1999-05-11
WO1995001186A1 (en) 1995-01-12
JP4572008B2 (ja) 2010-10-27
US6410053B1 (en) 2002-06-25
GB9313484D0 (en) 1993-08-11
EP0706401A1 (en) 1996-04-17
ES2185654T3 (es) 2003-05-01
PT706401E (pt) 2003-03-31
EP0706401B1 (en) 2002-11-27
DE69431800T2 (de) 2003-09-04
DE69431800D1 (de) 2003-01-09
AU7004194A (en) 1995-01-24

Similar Documents

Publication Publication Date Title
DK0706401T3 (da) Lægemiddelafgivelsessystem
ATE122879T1 (de) Verabreichungsformen für pharmaka.
US5656284A (en) Oral transmucosal delivery tablet and method of making it
WO2003077972A8 (en) Implantable drug delivery system
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
CS9004859A2 (en) Method of adhesive plaster production that contains oestrogen as active substance
BR9608542A (pt) Composição para a liberação sustentada de hormónio do crescimento humano
DE69508938D1 (de) Transdermales arzneistoff-abgabesystem
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
ATE516049T1 (de) Formulierung zur gesteuerten arzneistofffreisetzung durch kombination hydrophiler und hydrophober stoffe
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
AU7465087A (en) Controlled release bioerodible drug delivery system
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
IE860306L (en) Drug delivery system
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
ATE238774T1 (de) Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
BR9805444A (pt) Sistema de implante de pellet
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
EP0873751A3 (en) Pharmaceutical product for application to uterus mucosa
EP0325086A3 (en) Novel methods for obtaining therapeutic systems with controlled release of the drug
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction